ENTITY
Gilead Sciences

Gilead Sciences (GILD US)

160
Analysis
Health Care • United States
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
more
Company Presentation • 08 May 2026 04:30

Q1 2026

Company Presentation • 08 Apr 2026 04:30

M&A announcement

Company Presentation • 09 Jan 2024 02:30

J.P. Morgan 42nd Annual Healthcare Conference 2024

Company Presentation • 11 Feb 2026 05:30

Q4 2025

Company Presentation • 14 Jan 2025 03:15

43rd Annual J.P. Morgan Healthcare Conference 2025

x